DNOW’s (NYSE:DNOW) Q2 CY2026: Strong Sales, Stock Soars

DNOW (NYSE:DNOW) reported Q2 CY2026 results. Revenue rose 108% year on year to $1.31 billion, beating Wall Street estimates by 3.1%, according to the company. Non-GAAP adjusted EPS was $0.12, clearing analysts’ consensus, and the stock rose 5.6% to $15.01 after the release.

Original reporting
Published Aug 6, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DNOW’s (NYSE:DNOW) Q2 CY2026: Strong Sales, Stock Soars — source image
Decision brief

The 30-second read

$DNOWBullishMed
01

Why it matters

Q2 CY2026 delivered a large revenue beat and an adjusted EPS beat, supporting near-term sentiment, but the article flags worsening operating margin, breakeven margin, and declining EPS versus the prior year.

02

Market read

Traders can reassess DNOW’s near-term earnings trajectory after the Q2 beat, while monitoring whether margin compression reverses.

03

What to watch

Operating margin fell and breakeven margin slipped, plus share count rose 69.1%, which can dilute per-share gains even when revenue accelerates.

Relevance 7/10Novelty 6/10Timing: post-Q2 results, same-day reaction

Background

DNOW is an energy and industrial distributor spun off from National Oilwell Varco, serving distribution and supply chain solutions.

Company-level read

Ticker impact

$DNOWBullishMedium confidence
Context

DNOW reported Q2 CY2026 revenue up 108% to $1.31B and adjusted EPS of $0.12, beating consensus, with shares up 5.6% to $15.01.

Expected impact

Near-term bias remains upward on the earnings beat, but follow-through may be capped by margin compression and EPS decline versus last year.

Evidence & confidence

The article provides concrete beat metrics and same-day price reaction, while also highlighting margin and EPS deterioration that can temper sustained upside.

Market effects

Signals strength in energy and industrial distribution demand, but margin pressure suggests cost pass-through remains an issue for the group.

No specific regional demand or policy linkage mentioned.

No direct global macro or commodity linkage provided beyond end-market framing.

Counterpoint

The headline revenue surge may reflect a temporary demand or inventory cycle, while margin and EPS trends point to weaker underlying earnings power.

Key entities

  • DNOW

    Energy and industrial distributor reporting Q2 CY2026 results with revenue and adjusted EPS beats, plus margin deterioration.

Related articles

$DNOWHighAI 8/10

DNOW Q2 Earnings Call Highlights

DistributionNOW (DNOW) reported Q2 results and integration progress after acquiring MRC Global. Management said gas utility revenue rose 15% sequentially to an 11-quarter high, while downstream revenue fell $12 million. DNOW generated $133M operating cash flow, ended with $114M cash, and raised 2026 outlook to revenue of about $5.0B-$5.1B and EBITDA margin near 4.5%.

$DNOWMed

DNOW Inc. (DNOW): Results of Operations and Financial Condition

DNOW Inc. (DNOW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 dnow-ex99_1.htm EX-99.1 EX-99.1 Earnings Conference Call August 6, 2026 8:00 a.m. CT 1 (888) 660-6431 (within North America) 1 (929) 203-2118 (outside of North America) Access Code: 7372055 Webcast: ir.dnow.com DNOW Reports Second Quarter 2026 Results HOUSTON, TX, Augus

$DNOWLowAI 8/10

Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW

The Rosen Law Firm said it is investigating potential securities claims for DNOW Inc. (NYSE: DNOW) shareholders, alleging the company may have issued materially misleading business information. The notice cites a Feb. 20, 2026 StockStory report that DNOW shares fell 19.1% after Q4 2025 results showed a significant loss and missed expectations. The firm is preparing a class action and invites investors to join via its website or contact details.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.